Abstract:Guidelines suggest similar blood pressure (BP) targets in patients with and without diabetes and recommend ambulatory BP monitoring (ABPM) to diagnose and classify hypertension. It was explored whether different levels of ambulatory and office BP and different hypertension phenotypes associate with differences of risk in diabetes and no diabetes. This analysis assessed outcome data from the Spanish ABPM Registry in 59 124 patients with complete available data. The associations between office, mean, daytime, and nighttime ambulatory BP with the risk in patients with or without diabetes were explored. The effects of diabetes on mortality in different hypertension phenotypes, i.e. sustained hypertension, white-coat hypertension, and masked hypertension, compared with normotension were studied. Analyses were done with Cox regression analyses and adjusted for demographic and clinical confounders. A total of 59 124 patients were recruited from 223 primary care centres in Spain. The majority had an office systolic BP >140 mmHg (36 700 patients), and 23 128 (40.6%) patients were untreated. Diabetes was diagnosed in 11 391 patients (19.2%). Concomitant cardiovascular (CV) disease was present in 2521 patients (23.1%) with diabetes and 4616 (10.0%) without diabetes. Twenty-four-hour mean, daytime, and nighttime ambulatory BP were associated with increased risk in diabetes and no diabetes, while in office BP, there was no clear association with no differences with and without diabetes. While the relative association of BP to CV death risk was similar in diabetes compared with no diabetes (mean interaction P = .80, daytime interaction P = .97, and nighttime interaction P = .32), increased event rates occurred in diabetes for all ABPM parameters for CV death and all-cause death. White-coat hypertension was not associated with risk for CV death (hazard ratio 0.86; 95% confidence interval 0.72–1.03) and slightly reduced risk for all-cause death in no diabetes (hazard ratio 0.89; confidence interval 0.81–0.98) but without significant interaction between diabetes and no diabetes. Sustained hypertension and masked hypertension in diabetes and no diabetes were associated with even higher risk. There were no significant interactions in hypertensive phenotypes between diabetes and no diabetes and CV death risk (interaction P = .26), while some interaction was present for all-cause death (interaction P = .043) and non-CV death (interaction P = .053). Diabetes increased the risk for all-cause death, CV, and non-CV death at every level of office and ambulatory BP. Masked and sustained hypertension confer to the highest risk, while white-coat hypertension appears grossly neutral without interaction of relative risk between diabetes and no diabetes. These results support recommendations of international guidelines for strict BP control and using ABPM for classification and assessment of risk and control of hypertension, particularly in patients with diabetes. Not applicable. Main findings on office vs. ambulatory blood pressure monitoring and their association with mortality in patients with and without diabetes from the Spanish Ambulatory Blood Pressure Monitoring Registry on 59 124 patients. SBP, systolic blood pressure.

Resistant Hypertension and Mortality: An Observational Cohort Study

[Resistant hypertension and the risk of major adverse cardiac and cerebrovascular events in outpatients]

Prevalence and prognosis of refractory hypertension diagnosed using ambulatory blood pressure measurements

Blood pressure and 10-year all-cause mortality: Findings from the PERU MIGRANT Study

Longitudinal Change in Blood Pressure is Associated with Cardiovascular Disease Mortality in a Chinese Cohort.

Office measurement vs. ambulatory blood pressure monitoring: associations with mortality in patients with or without diabetes

EVALUATING THE PROGNOSTIC VALUE OF DIFFERENT BLOOD PRESSURE PHENOTYPES ON AMBULATORY BLOOD PRESSURE MONITORING IN WOMEN

Clinic and ambulatory blood pressures, blood pressure phenotypes and mortality in patients with a previous stroke

Baseline and Longitudinal Change in Blood Pressure and Mortality in a Chinese Cohort

A Comparative Meta-Analysis of Prospective Observational Studies on Masked Hypertension and Masked Uncontrolled Hypertension Defined by Ambulatory and Home Blood Pressure

Influence of hypertension duration and blood pressure levels on cardiovascular disease and all-cause mortality: A large prospective cohort study

Correlation between systolic blood pressure and mortality in heart failure patients with hypertension

Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population.

Prognostic Relevance of Short-Term Blood Pressure Variability. The Spanish ABPM Registry

Ambulatory Hypertension Subtypes and 24-Hour Systolic and Diastolic Blood Pressure As Distinct Outcome Predictors in 8341 Untreated People Recruited from 12 Populations.

Significance of WhiteCoat Hypertension in Older Persons with Isolated Systolic Hypertension

Prevalence, Clinical Characteristics, and Treatment of Patients with Resistant Hypertension: A Single-Center Study

Combined effect of time in target range and variability of systolic blood pressure on cardiovascular outcomes and mortality in patients with hypertension: A prospective cohort study

Risk Stratification by Ambulatory Blood Pressure Monitoring Across Jnc Classes of Conventional Blood Pressure

Association of Office and Ambulatory Blood Pressure with Mortality and Cardiovascular Outcomes.

Systolic Blood Pressure and Outcomes in Stable Outpatients with Recent Symptomatic Artery Disease: A Population-Based Longitudinal Study